Structural characterization of antibody-responses following Zolgensma treatment for AAV capsid engineering to expand patient cohorts
Nat Commun. 2025 Apr 19;16(1):3731. doi: 10.1038/s41467-025-59088-4. ABSTRACT Monoclonal antibodies are useful tools to dissect the neutralizing antibody response against the adeno-associated virus (AAV) capsids …